Fundz

Shasqi Raises $50 Million To Expand Click Chemistry Platform Beyond Injectable Tumors And Accelerate Lead Clinical Program

PRIVATENov 11, 2021

Amount Raised

$50 Million

Round Type

Funding Round

San FranciscoBiotechnologyHealth Care

Description

Shasqi, a clinical-stage biotechnology company developing precision activated oncology therapeutics with its proprietary Click Activated Protodrugs Against Cancer (CAPACTM) Platform, announced today a Series B funding round of $50 million driven by a syndicate of private investors, including Juan Jaen, Ph.D., President of Arcus Biosciences and Bill Rieflin, Executive Chairman of the Board at NGM Biopharmaceuticals. The funds will be used to advance the Phase 1/2 clinical study of SQ3370 for the treatment of injectable, advanced solid tumors, and will enable Shasqi to expand its click chemistry platform to create therapeutics that do not require intratumoral injections.

Quick answer

Shasqi raised $50 Million in a Funding Round round, dated November 11, 2021. Shasqi is based in San Francisco, California, United States.

How much did Shasqi raise?
Shasqi raised $50 Million in a Funding Round round on November 11, 2021.
What does Shasqi do?
Shasqi, Inc. is a biotech company with a mission to make cancer drugs more effective with click chemistry.
Where is Shasqi based and how big is it?
Shasqi is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Shasqi that raised within 45 days of this round, from Fundz verified event records.

  • Rhaeos raised $2.2M (Seed) on December 24, 2021.
  • Arcutis raised $225M (Debt Financing) on December 23, 2021.
  • Vero Biotech Inc. raised $27M on December 22, 2021.
  • Appili Therapeutics Inc. raised an undisclosed amount (Funding Round) on December 22, 2021.
  • TandemAI raised $25M (Seed) on December 22, 2021.
  • Galectin raised an undisclosed amount (Debt Financing) on December 21, 2021.

Who to call at Shasqi, and when

A new round usually means Shasqi is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Shasqi raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Shasqi, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Shasqi. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Shasqi

Location

San Francisco, California, United States

About

Shasqi, Inc. is a biotech company with a mission to make cancer drugs more effective with click chemistry. The company has developed the CAPAC® (Click Activated Protodrugs Against Cancer) platform, utilizing 2022 Nobel Prize winning technology, click chemistry, to selectively activate high doses of cancer drugs directly at the site of the tumor, minimizing toxicity to healthy cells and potentially improving the therapeutic index by dramatically altering the exposure.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Shasqi raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Shasqi's next move

See what Strategic adds

Shasqi raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.